Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Harry Sweigard

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Visualized Experiments : Jove|January 16, 2015
Assessing leukocyte-endothelial interactions under flow conditions in an ex vivo autoperfused microflow chamber assayLama Mulki, J Harry Sweigard, Kip M Connor
Investigative Ophthalmology & Visual Science|November 7, 2009
Adenovirus vectors targeting distinct cell types in the retinaJ Harry Sweigard, Siobhan M Cashman, Rajendra Kumar-Singh
Investigative Ophthalmology & Visual Science|August 7, 2010
Decay accelerating factor (CD55)-mediated attenuation of complement: therapeutic implications for age-related macular degenerationKelly N Ma, Siobhan M Cashman, J Harry Sweigard, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 27, 2014
The alternative complement pathway regulates pathological angiogenesis in the retinaJ Harry Sweigard, Ryoji Yanai, Philipp Gaissert, et al.
Science Translational Medicine|July 24, 2015
Inhibition of the alternative complement pathway preserves photoreceptors after retinal injuryJ Harry Sweigard, Hidetaka Matsumoto, Kaylee E Smith, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|January 16, 2015
Assessing leukocyte-endothelial interactions under flow conditions in an ex vivo autoperfused microflow chamber assayLama Mulki, J Harry Sweigard, Kip M Connor
Investigative Ophthalmology & Visual Science|November 7, 2009
Adenovirus vectors targeting distinct cell types in the retinaJ Harry Sweigard, Siobhan M Cashman, Rajendra Kumar-Singh
Investigative Ophthalmology & Visual Science|August 7, 2010
Decay accelerating factor (CD55)-mediated attenuation of complement: therapeutic implications for age-related macular degenerationKelly N Ma, Siobhan M Cashman, J Harry Sweigard, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 27, 2014
The alternative complement pathway regulates pathological angiogenesis in the retinaJ Harry Sweigard, Ryoji Yanai, Philipp Gaissert, et al.
Science Translational Medicine|July 24, 2015
Inhibition of the alternative complement pathway preserves photoreceptors after retinal injuryJ Harry Sweigard, Hidetaka Matsumoto, Kaylee E Smith, et al.
Pageof 1